Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial.
about
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.Orlistat: current status in clinical therapeutics.Crigler-Najjar syndrome type 2: Novel UGT1A1 mutationReduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.I read with great interest the article by Hafkamp et al.
P2860
Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Orlistat treatment of unconjug ...... a randomized controlled trial.
@en
Orlistat treatment of unconjug ...... a randomized controlled trial.
@nl
type
label
Orlistat treatment of unconjug ...... a randomized controlled trial.
@en
Orlistat treatment of unconjug ...... a randomized controlled trial.
@nl
prefLabel
Orlistat treatment of unconjug ...... a randomized controlled trial.
@en
Orlistat treatment of unconjug ...... a randomized controlled trial.
@nl
P2093
P2860
P1433
P1476
Orlistat treatment of unconjug ...... a randomized controlled trial.
@en
P2093
Anja M Hafkamp
Henkjan J Verkade
Maarten Sinaasappel
Rineke Nelisse-Haak
Ronald P J Oude Elferink
P2860
P2888
P304
P356
10.1203/PDR.0B013E3181598CC5
P407
P577
2007-12-01T00:00:00Z
P6179
1028144871